(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OXAPEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OXAPEX

ST13

US500000090696150

Class

5, 44

Filing

90696150

Registration

6824225

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

08/23/2022

Trademark type

Combined

Nice classes

5, 44

Filing date

05/07/2021

Registration date

08/23/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/23/2022

Last transaction

08/23/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

16

Owner location

Hong Kong, HK

Examiner

MCMORROW, JANICE LEE

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized word "Oxapex" written in blue with the exception of the letter "a" which is represented with the Greek character alpha written in red.

Holders and representatives

Holders

First Gain International Limited

Representatives

Timothy T. Wang NI, WANG & MASSAND, PLLC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Human and veterinary pharmaceutical preparations for the prevention and treatment of cardiovascular disorderstissue hypoxiashock and anemia; Human and veterinary pharmaceutical preparations to increase plasma oxygen content; Biological preparations for medical and veterinary purposesSterile Solutions for use in Oxygen therapeutics for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases; biological preparations for medical and veterinary purposeshemoglobin solution for pharmaceutical purpose and intravenous infusion solutions of a synthetic colloids and crystalloids all for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases; Biological preparations for medical and veterinary purposesprotein arraysbiological tissue culturesbloodblood plasmablood serums for the treatment of cardiovascular disorderstissue hypoxiashockanemiaGastrointestinal and Hepatobiliary System diseaseCardiovascular and Hematopoietic System diseasesRespiratory System diseasesCentral Nervous System diseasesMusculo-Skeletal System diseasesHormones related diseasesOncology diseasesGenito-Urinary System diseasesEndocrine and Metabolic System diseasesEye diseasesEar and Mouth or Throat diseasesSkin diseasesAllergy and Immune System diseases

Class 44

Medical serviceshealthcare services in the nature of medical informationhospital servicesmedical assistance servicesmedical clinic servicestherapy servicesphysical therapy; Veterinary services in the nature of veterinary information; Hygienic and beauty care for human beings or animals

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/23/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/23/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/07/2022

PUBO

PUBLISHED FOR OPPOSITION

06/07/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/18/2022

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

05/03/2022

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/29/2022

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

04/26/2022

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/22/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/20/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/19/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/19/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/19/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/12/2022

GNRT

NON-FINAL ACTION E-MAILED

01/12/2022

CNRT

NON-FINAL ACTION WRITTEN

01/12/2022

DOCK

ASSIGNED TO EXAMINER

01/12/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

08/10/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/09/2021

NWAP

NEW APPLICATION ENTERED

05/11/2021

Continuous trademark protection

Get notified about every new filing that threatens OXAPEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.